Thyroid
General
Radiotracers
I-123
Only used in imaging
Decay via electron capture
T ½ = 13 hours
159 keV
If breastfeeding, can resume 3 days after test
I-131
Used in imaging and treatment
Decay via beta emission
High radiation, so preferably not used in regular imaging because of higher radiation dose
T1/2 = 8 days
364 keV
Should not be used in pregnant women
If breastfeeding, need to stop and discard any pumped milk
Tc-99m
Note you will see salivary glands in Tc study, will not see in I-123
Preferred over I-123 for imaging when
Receiving thyroid blocking agents (iodinated contrast)
Unable to take oral medication
Study must be completed in < 2 hours
If breastfeeding, can resume 12-24 hours after test
Iodine Uptake Test
Purpose
Given before starting radioiodine therapy to ensure that the thyroid will uptake iodine and to determine how much it will uptake
Not used to diagnose hyper/hypothyroidism, but can differentiate between Graves, subacute thyroiditis and factitious hyperthyroidism
Basically you give radioactive iodine and see how much is taken up by the thyroid to see how it normally handles iodine intake
High levels = more active thyroid gland
Low levels = less active thyroid gland
Uptake
Given as a percentage of the administered activity in the thyroid gland at a specific time
Normal Values
6-8% for 4-6 hours
10-30% for 24 hours
Factors affecting uptake
High iodine diet = competition for the drug = artificially low tracer uptake
Low iodine diet = no competition for the drug = artificially increased tracer uptake
Drugs (anti-thyroid drugs)
Propranolol has NO EFFECT
Chronic kidney disease = do not clear iodine = higher iodine in body = competition for tracer = decreased tracer uptake
Interpretation
Increased tracer uptake
Primary hyperthyroidism
Graves
Toxic nodular goiter (Plummer’s disease)
Secondary hyperthyroidism
Decreased tracer uptake
Primary hypothyroidism (gland does not respond to TSH)
Secondary hypothyroidism (pituitary does not secrete enough TSH)
Toxic Adenoma
Treatment
First treatment should not exceed 33 mCi I-131
30 mCi I-131 would be an appropriate first dose
Iodine Scan & MIBG
Iodine scan
You should not see liver unless there is pathology present that would make it visible
I.e. If you have active thyroid tissue or mets that are metabolizing thyroglobulin then the by products are sent to the liver for further degradation and therefore the liver lights up
Iodine 131
Iodine 123 - preferred over I-131 because it does not have beta radiation
Beta radiation has no benefit or use in imaging but still acts as radiation so you would be giving a stronger amount of radiation which could be harmful to patient with no added benefit
MIBG
You will see liver normally
If a kid, typical question asks about a neuroblastoma
Need to be able to state dosing for Iodine ablation (high dose, low dose, cancer treatment dosing, etc)
Parathyroid Scan
Agent = Tc-99m-sestamibi
Localizes in mitochondria of parathyroid cells
20 mci IV
Images at 15 min, 1 hour, 3 hours
No real prep
High sensitivity for primary hyperparathyroidism, lower for secondary
Normal thyroid tissue will show uptake that gradually decreases over time
Note: Parathyroid adenomas can occur really anywhere in the region of the neck so be sure to not only look posterior to the thyroid but also by esophagus, carotids, etc.
Thyroid adenomas and parathyroid hyperplasia
Significantly increased uptake relative to the normal background thyroid but will also show decreased amount over time
Parathyroid Adenoma
Significantly increased uptake relative to thyroid and will retain uptake on delayed images (hot quick and stays hot)
If the delayed images are equivocal or unsure still —> inject with free Tc
If nodule gets hot —> thyroid adenoma
If node looks cold —> parathyroid adenoma
References:
Parathyroid
Typically looking for parathyroid adenoma
Most commonly located inferior or posterior to the thyroid
Tc-99m Sestamibi - primary agent used most commonly
Fat soluble
Accumulates in cells with high mitochondrial activity
Tc-99m tetrofosmin
Second line typically f
F-18 Fluorocholine PET-CT
Increasingly used, typically when other study is inconclusive or it is a re-operative case
Higher sensitivity vs sestamibi
Uptake in cells with high phospholipid metabolism